Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
Sell
47
HCP Quote, Financials, Valuation and Earnings
Last price:
$34.31
Seasonality move
:
-8.12%
Day range:
$34.24 - $34.40
52-week range:
$20.89 - $34.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
10.50x
P/B ratio:
5.57x
Volume:
2.6M
Avg. volume:
2.3M
1-year change:
56.8%
Market cap:
$7B
Revenue:
$583.1M
EPS (TTM):
-$0.60
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $121.3M | $211.9M | $320.8M | $475.9M | $583.1M | |
| Revenue Growth (YoY) | -- | 74.71% | 51.41% | 48.36% | 22.54% | |
| Cost of Revenues | $23.9M | $41.1M | $63.4M | $87M | $108.7M | |
| Gross Profit | $97.3M | $170.8M | $257.3M | $388.9M | $474.4M | |
| Gross Profit Margin | 80.28% | 80.62% | 80.22% | 81.73% | 81.36% | |
| R&D Expenses | $40.1M | $65.2M | $165M | $195.4M | $222.6M | |
| Selling, General & Admin | $113.4M | $189.6M | $381.6M | $490.8M | $506.2M | |
| Other Inc / (Exp) | $3.4M | -- | -$157K | -$2.4M | -$510K | |
| Operating Expenses | $153.6M | $254.8M | $546.6M | $686.2M | $728.7M | |
| Operating Income | -$56.2M | -$84M | -$289.3M | -$297.3M | -$254.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$52.8M | -$83.3M | -$289.2M | -$273.3M | -$189.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $535K | $262K | $986K | $1M | $1M | |
| Net Income to Company | -$53.4M | -$83.5M | -$290.1M | -$274.3M | -$190.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$53.4M | -$83.5M | -$290.1M | -$274.3M | -$190.7M | |
| Basic EPS (Cont. Ops) | -$0.33 | -$0.51 | -$3.48 | -$1.47 | -$0.98 | |
| Diluted EPS (Cont. Ops) | -$0.33 | -$0.51 | -$3.48 | -$1.47 | -$0.98 | |
| Weighted Average Basic Share | $163.9M | $163.9M | $83.3M | $186M | $193.8M | |
| Weighted Average Diluted Share | $163.9M | $163.9M | $83.3M | $186M | $193.8M | |
| EBITDA | -$56M | -$83.1M | -$286.8M | -$292.7M | -$244.8M | |
| EBIT | -$56.2M | -$84M | -$289.3M | -$297.3M | -$254.3M | |
| Revenue (Reported) | $121.3M | $211.9M | $320.8M | $475.9M | $583.1M | |
| Operating Income (Reported) | -$56.2M | -$84M | -$289.3M | -$297.3M | -$254.3M | |
| Operating Income (Adjusted) | -$56.2M | -$84M | -$289.3M | -$297.3M | -$254.3M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $55.2M | $82.2M | $125.3M | $146.1M | $173.4M | |
| Revenue Growth (YoY) | 65.08% | 48.84% | 52.44% | 16.58% | 18.66% | |
| Cost of Revenues | $10.4M | $11.1M | $22.5M | $25.6M | $29.8M | |
| Gross Profit | $44.9M | $71.1M | $102.8M | $120.5M | $143.6M | |
| Gross Profit Margin | 81.22% | 86.45% | 82.01% | 82.48% | 82.82% | |
| R&D Expenses | $15.1M | $25.7M | $53.9M | $54.3M | $53.4M | |
| Selling, General & Admin | $39.2M | $67M | $126.2M | $121.7M | $120.1M | |
| Other Inc / (Exp) | $84K | -$16K | -$2.9M | -$407K | $100K | |
| Operating Expenses | $54.2M | $92.6M | $180.1M | $176.1M | $173.5M | |
| Operating Income | -$9.3M | -$21.5M | -$77.3M | -$55.6M | -$29.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$9.3M | -$21.5M | -$71.6M | -$39.2M | -$12.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $54K | $418K | $322K | $258K | $611K | |
| Net Income to Company | -- | -$22M | -$72M | -$39.5M | -$13M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$9.3M | -$22M | -$72M | -$39.5M | -$13M | |
| Basic EPS (Cont. Ops) | -$0.06 | -$0.12 | -$0.38 | -$0.20 | -$0.06 | |
| Diluted EPS (Cont. Ops) | -$0.06 | -$0.12 | -$0.38 | -$0.20 | -$0.06 | |
| Weighted Average Basic Share | $163.9M | $178.9M | $187.1M | $194.6M | $203.5M | |
| Weighted Average Diluted Share | $163.9M | $178.9M | $187.1M | $194.6M | $203.5M | |
| EBITDA | -$9.1M | -$21M | -$76.1M | -$52.9M | -$26.4M | |
| EBIT | -$9.3M | -$21.5M | -$77.3M | -$55.6M | -$29.9M | |
| Revenue (Reported) | $55.2M | $82.2M | $125.3M | $146.1M | $173.4M | |
| Operating Income (Reported) | -$9.3M | -$21.5M | -$77.3M | -$55.6M | -$29.9M | |
| Operating Income (Adjusted) | -$9.3M | -$21.5M | -$77.3M | -$55.6M | -$29.9M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $189.2M | $286.1M | $436.6M | $563.1M | $654.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $37.3M | $48.2M | $90.2M | $105.2M | $117.3M | |
| Gross Profit | $151.9M | $237.9M | $346.4M | $457.9M | $537.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $61.1M | $84.6M | $245.3M | $214.9M | $221.2M | |
| Selling, General & Admin | $182M | $222.5M | $562.8M | $511.8M | $505.6M | |
| Other Inc / (Exp) | $1.2M | $156K | -$3M | -$75K | $2K | |
| Operating Expenses | $243M | $307.1M | $808.1M | $726.8M | $726.8M | |
| Operating Income | -$91.1M | -$69.2M | -$461.7M | -$268.9M | -$189.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$90M | -$69M | -$451.4M | -$207.7M | -$119.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $605K | $341K | $1.3M | $749K | $2.5M | |
| Net Income to Company | -- | -- | -$452.6M | -$208.4M | -$122.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$90.6M | -$69.3M | -$452.6M | -$208.4M | -$122.2M | |
| Basic EPS (Cont. Ops) | -$0.55 | -$0.41 | -$2.91 | -$1.08 | -$0.60 | |
| Diluted EPS (Cont. Ops) | -$0.55 | -$0.41 | -$2.91 | -$1.08 | -$0.60 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$90.9M | -$67.5M | -$457.5M | -$260.9M | -$176.4M | |
| EBIT | -$91.1M | -$69.2M | -$461.7M | -$268.9M | -$189.2M | |
| Revenue (Reported) | $189.2M | $286.1M | $436.6M | $563.1M | $654.9M | |
| Operating Income (Reported) | -$91.1M | -$69.2M | -$461.7M | -$268.9M | -$189.2M | |
| Operating Income (Adjusted) | -$91.1M | -$69.2M | -$461.7M | -$268.9M | -$189.2M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $150M | $224.2M | $340.1M | $427.4M | $499.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $29.6M | $36.7M | $63.5M | $81.7M | $90.3M | |
| Gross Profit | $120.4M | $187.5M | $276.6M | $345.6M | $408.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $49.4M | $68.7M | $148.9M | $168.5M | $167.2M | |
| Selling, General & Admin | $147.9M | $180.9M | $362.1M | $383.1M | $382.5M | |
| Other Inc / (Exp) | $627K | $27K | -$2.9M | -$632K | -$120K | |
| Operating Expenses | $197.3M | $249.6M | $511M | $551.6M | $549.7M | |
| Operating Income | -$76.9M | -$62M | -$234.4M | -$206M | -$140.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$76.2M | -$62M | -$224.2M | -$158.6M | -$88.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $400K | $479K | $744K | $480K | $1.9M | |
| Net Income to Company | -- | -$62.4M | -$224.9M | -$159M | -$90.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$76.6M | -$62.4M | -$224.9M | -$159M | -$90.6M | |
| Basic EPS (Cont. Ops) | -$0.47 | -$0.37 | -$1.21 | -$0.82 | -$0.45 | |
| Diluted EPS (Cont. Ops) | -$0.47 | -$0.37 | -$1.21 | -$0.82 | -$0.45 | |
| Weighted Average Basic Share | $491.8M | $506.8M | $555.2M | $578M | $605.5M | |
| Weighted Average Diluted Share | $491.8M | $506.8M | $555.2M | $578M | $605.5M | |
| EBITDA | -$76.6M | -$60.6M | -$231.2M | -$199.4M | -$131M | |
| EBIT | -$76.9M | -$62M | -$234.4M | -$206M | -$140.9M | |
| Revenue (Reported) | $150M | $224.2M | $340.1M | $427.4M | $499.1M | |
| Operating Income (Reported) | -$76.9M | -$62M | -$234.4M | -$206M | -$140.9M | |
| Operating Income (Adjusted) | -$76.9M | -$62M | -$234.4M | -$206M | -$140.9M | |
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $110.5M | $270.8M | $1.4B | $1.3B | $763.4M | |
| Short Term Investments | $30M | -- | -- | -- | $515.2M | |
| Accounts Receivable, Net | $52.1M | $93.5M | $126.8M | $162.4M | $182.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $7.4M | $4.6M | $17.7M | $17.7M | $30.1M | |
| Total Current Assets | $208.7M | $384.1M | $1.5B | $1.5B | $1.5B | |
| Property Plant And Equipment | $21M | $24M | $31.3M | $37.2M | $45.4M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | $12.2M | |
| Other Intangibles | -- | -- | -- | -- | $11.6M | |
| Other Long-Term Assets | $1.8M | $2.2M | $2.6M | $902K | $1.1M | |
| Total Assets | $253.1M | $445.3M | $1.6B | $1.6B | $1.7B | |
| Accounts Payable | $5.4M | $5.2M | $14.3M | $12.5M | $9.1M | |
| Accrued Expenses | $753K | $569K | $3.9M | $32.1M | $26.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $1.7M | $2.4M | $3.1M | $3.4M | $4M | |
| Other Current Liabilities | $130K | $24K | $6K | $670K | $6.1M | |
| Total Current Liabilities | $127.9M | $187.3M | $308.7M | $380.8M | $440.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $333.4M | $567.1M | $341.4M | $423M | $479M | |
| Common Stock | $1K | $1K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -- | -$393K | |
| Common Equity | -$80.2M | -$121.8M | $1.3B | $1.2B | $1.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$80.2M | -$121.8M | $1.3B | $1.2B | $1.2B | |
| Total Liabilities and Equity | $253.1M | $445.3M | $1.6B | $1.6B | $1.7B | |
| Cash and Short Terms | $140.5M | $270.8M | $1.4B | $1.3B | $1.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $218.2M | $1.3B | $729.8M | $923.6M | |
| Short Term Investments | -- | -- | -- | $525.8M | $422.8M | |
| Accounts Receivable, Net | -- | $85.5M | $115.3M | $108.2M | $129.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | $8.5M | $14.4M | $29.2M | $26.2M | |
| Total Current Assets | -- | $335.8M | $1.4B | $1.4B | $1.6B | |
| Property Plant And Equipment | -- | $27.7M | $35.4M | $42.3M | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | $12.3M | $12.2M | |
| Other Intangibles | -- | -- | -- | $12.3M | $9.5M | |
| Other Long-Term Assets | -- | $6.4M | $2.5M | $1.1M | $47M | |
| Total Assets | -- | $418.9M | $1.6B | $1.6B | $1.7B | |
| Accounts Payable | -- | $10.2M | $16.4M | $6.1M | $21.1M | |
| Accrued Expenses | -- | $2M | $23.7M | $38.2M | $14.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | $3.1M | $3.3M | $3.7M | -- | |
| Other Current Liabilities | -- | $9K | $2.5M | $3.9M | -- | |
| Total Current Liabilities | -- | $214.8M | $319M | $357.9M | $410.1M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $595M | $346.2M | $394.5M | $435.3M | |
| Common Stock | -- | $1K | $3K | $3K | $3K | |
| Other Common Equity Adj | -- | -- | -- | -$1.2M | $379K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -$176.1M | $1.2B | $1.2B | $1.3B | |
| Total Liabilities and Equity | -- | $418.9M | $1.6B | $1.6B | $1.7B | |
| Cash and Short Terms | -- | $218.2M | $1.3B | $1.3B | $1.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$53.4M | -$83.5M | -$290.1M | -$274.3M | -$190.7M | |
| Depreciation & Amoritzation | $235K | $888K | $2.5M | $4.6M | $9.5M | |
| Stock-Based Compensation | $9.5M | $39.2M | $200.6M | $171.2M | $170.6M | |
| Change in Accounts Receivable | -$27.7M | -$41.4M | -$33.4M | -$35.6M | -$20.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$28.4M | -$39.6M | -$56.2M | -$84.5M | -$10.9M | |
| Capital Expenditures | $980K | $7.2M | $6.6M | $9M | $12M | |
| Cash Acquisitions | -- | -- | -- | -- | -$20.9M | |
| Cash From Investing | $46M | $22.8M | -$6.6M | -$9M | -$535.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$229K | -$110.2M | -$248K | -$269K | |
| Cash From Financing | $1.1M | $177.1M | $1.1B | $22M | $23.3M | |
| Beginning Cash (CF) | $93.6M | $112.3M | $272.6M | $1.4B | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $18.7M | $160.3M | $1.1B | -$71.5M | -$522.7M | |
| Ending Cash (CF) | $112.3M | $272.6M | $1.4B | $1.3B | $763.4M | |
| Levered Free Cash Flow | -$29.3M | -$46.8M | -$62.8M | -$93.5M | -$22.9M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$22M | -$72M | -$39.5M | -$13M | |
| Depreciation & Amoritzation | -- | $558K | $1.2M | $2.7M | $3.5M | |
| Stock-Based Compensation | -- | $1.5M | $46.7M | $43.8M | $34.5M | |
| Change in Accounts Receivable | -- | -$11M | -$3.7M | $14.2M | $18.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$23.1M | -$15.2M | $8.7M | $38.2M | |
| Capital Expenditures | -- | $1.9M | $2.7M | $2.9M | $2.4M | |
| Cash Acquisitions | -- | -- | -- | -$1K | -- | |
| Cash From Investing | -- | -$1.9M | -$2.7M | -$110.3M | $90.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2M | -$20K | -$12K | -$3.5M | |
| Cash From Financing | -- | -$990K | $969K | $1.5M | -$2.3M | |
| Beginning Cash (CF) | -- | $245.9M | $1.3B | $830M | $797.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$25.9M | -$16.9M | -$100.2M | $126.4M | |
| Ending Cash (CF) | -- | $220M | $1.3B | $729.8M | $923.6M | |
| Levered Free Cash Flow | -- | -$24.9M | -$17.9M | $5.7M | $35.7M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$452.6M | -$208.4M | -$122.2M | |
| Depreciation & Amoritzation | -- | -- | $4.2M | $8M | $12.8M | |
| Stock-Based Compensation | -- | $4.8M | $331.2M | $165.8M | $162.1M | |
| Change in Accounts Receivable | -- | -- | -$29.7M | $7M | -$21.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$93M | -$19.6M | $68M | |
| Capital Expenditures | -- | $4.7M | $8.2M | $11.7M | $10.8M | |
| Cash Acquisitions | -- | -- | -- | -$20.9M | -- | |
| Cash From Investing | -- | -- | -$8.2M | -$550.8M | $108.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$108.4M | -$262K | -$3.6M | |
| Cash From Financing | -- | -- | $1.2B | $23.5M | $17.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $1.1B | -$546.9M | $193.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$101.2M | -$31.3M | $57.2M | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$62.4M | -$224.9M | -$159M | -$90.6M | |
| Depreciation & Amoritzation | -- | $1.5M | $3.2M | $6.6M | $9.9M | |
| Stock-Based Compensation | -- | $4.8M | $135.4M | $130M | $121.6M | |
| Change in Accounts Receivable | -- | $7.9M | $11.5M | $54.1M | $53.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$49.2M | -$86M | -$21.1M | $57.7M | |
| Capital Expenditures | -- | $4.7M | $6.3M | $9M | $7.8M | |
| Cash Acquisitions | -- | -- | -- | -$20.9M | -- | |
| Cash From Investing | -- | -$4.7M | -$6.3M | -$548.1M | $95.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$2M | -$222K | -$236K | -$3.6M | |
| Cash From Financing | -- | $1.3M | $11.4M | $12.9M | $6.9M | |
| Beginning Cash (CF) | -- | $793.9M | $4B | $3.1B | $2.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$52.6M | -$80.9M | -$556.3M | $160.2M | |
| Ending Cash (CF) | -- | $741.3M | $3.9B | $2.5B | $2.3B | |
| Levered Free Cash Flow | -- | -$54M | -$92.4M | -$30.2M | $49.9M | |
Get HCP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HCP
Sector
P/E ratio
--
25.52x
PEG ratio
--
0.05x
P/B ratio
5.57x
2.51x
Price / LTM sales
10.50x
1.91x
Growth Metrics
HCP
Sector
Revenue growth
18.66%
4.33%
Earnings growth
--
8.94%
Revenue (5-year growth)
--
6.47%
Earnings forecast
$0.05
$0.14
Profitability
HCP
Sector
Profitability FY 2023
$474.4M
$99.3M
Return on invested capital
-10.01%
1.79%
Return on assets
-7.36%
0.52%
Return on equity
-10.01%
2.9%
Earnings Date
Last Earnings Date
Dec
5
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
HCP
Sector
Total cash
$1.3B
$58.2M
Short term investments
$515.2M
$27.3M
Total assets
$1.7B
$282.7M
Long term debt
--
$4.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
